Sat May 7 00:50:41 SGT 2016  
SINGAPORE
BOTOX™
    Botox® cost, Singapore (SG)

Botox® cost, Singapore (SG)

Summary

Botox® cost, Singapore (SG) @singaporebotox_com: Botox® Cosmetic, Dysport®, BTX-A, botulinum toxin type A injection, wrinkle removal treatment clinic, Singapore. Cost/price for treating glabella frown lines, crow's feet, and horizontal forehead lines. Definitions, references, and latest news.

Description

Botox® price. Average Botox® cost.

AreaIU/spotSpotsTotal IUPrice @ SG$15/IU
Horizontal forehead lines2816SG$240
Glabellar frown lines4520SG$300
Crow's feet4624SG$360
ConsultationSG$38
TotalSG$938

Jaw slimming / face slimming / Botox® jaw reduction / Botox® jaw slimming / Botox® face slimming price.

AreaIU/spotSpotsTotal IUPrice @ SG$15/IU
Jaw reduction8 to 12656SG$840
ConsultationSG$38
TotalSG$878

Botox® treatment is with the original Allergan Botox® Cosmetic

  • The units differ for different brands.
  • Price quoted is for average ladies face, with average musculature.
  • Muscular men might require up to twice as much.
  • Minimum charge is for 10 units.

Botox® is one of the trade names for botulinum toxin, which is a protein produced by the bacterium clostridium botulinum.

Aesthetic services available:

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: www.shimclinic.com
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

References


Latest News

Mp67-01 preliminary evidence suggests periureteral botulinum toxin type a injection improves ureteral stone passage in the porcine model
Mon, 28 Mar 2016 19:24:06 +0100 | The Journal of Urology
We evaluated the use of periureteral injection of botulinum toxin type A (Botox®, BTX-A) to facilitate passage of ureteral stones in a porcine model. We believe that reducing detrusor muscle tone around the intramural ureter may facilitate passage of ureteral stones through the ureterovesical junction. (Source: The Journal of Urology)

Mp17-12 serial botulinum toxin injections offer durable results for neurogenic bladder: 4 year urodynamic outcomes
Mon, 28 Mar 2016 19:24:01 +0100 | The Journal of Urology
We report on urodynamic (UDS) outcomes at mean 44 months after initiating serial BTxA injections. (Source: The Journal of Urology)

Prevention of esophageal strictures after endoscopic submucosal dissection with the injection of botulinum toxin type A
Sun, 27 Mar 2016 22:00:00 +0100 | Gastrointestinal Endoscopy
Use of endoscopic submucosal dissection (ESD) for management of widespread superficial esophageal squamous carcinoma is closely associated with esophageal stenosis. We aimed to investigate the efficacy and feasibility of endoscopic injection of botulinum toxin type A (BTX-A) for preventing esophageal strictures after ESD for superficial esophageal squamous carcinoma. (Source: Gastrointestinal Endoscopy)

Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
Thu, 24 Mar 2016 11:39:02 +0100 | Journal of the Medical Association of Thailand = Chotmaihet thangphaet
CONCLUSION: The efficacy in VAS reduction of a single 20 IU of Botulinum toxin type A (Botox®) injection was not different from 0.9% NaCl for myofascial trigger point at the upper trapezius muscle. However Botulinum toxin type A (Botox®) showed statistically significant more increased in pressure pain threshold at 6-week after injection without severe adverse effects.

The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache
Wed, 23 Mar 2016 23:00:00 +0100 | The Journal of Headache and Pain
Conclusions

Botox Alleviates Neuropathic PainBotox Alleviates Neuropathic Pain
Wed, 23 Mar 2016 12:56:51 +0100 | Medscape Neurology and Neurosurgery Headlines
A series of two doses of botulinum toxin A relieved neuropathic pain better than did placebo, new randomized findings show. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)

Prior treatment does not influence the performance or early outcome of per-oral endoscopic myotomy for achalasia
Wed, 23 Mar 2016 06:34:36 +0100 | Surgical Endoscopy
Conclusion

Randomized, double-blind control trial of peri-articular hyaluronic acid: Botulinus toxin ve placebo injection in lateral epicondylosis
Sun, 20 Mar 2016 18:07:31 +0100 | Osteoarthritis and Cartilage
Purpose: To compare and describe the effects of peri-articular hyaluronic acid (HA) coadminsitered with botulinus toxin (HA + Botox) versus placebo in lateral epicondylosis. (Source: Osteoarthritis and Cartilage)

X Factor winner Sam Bailey considering Botox to reduce wrinkles
Sun, 20 Mar 2016 00:55:51 +0100 | the Mail online | Health
Sam, who is currently on a nationwide tour with the hit musical, revealed she is considering Botox in an effort to turn back the clock and say goodbye to her wrinkles. (Source: the Mail online | Health)

Caregiver Satisfaction for Orthotic Management of a Severely Involved Child with Cerebral Palsy Seen at Age 7 Years and 19 Years
Sat, 19 Mar 2016 01:34:19 +0100 | JPO Journal of Prosthetics and Orthotics
Conclusions: The primary caregiver is the key regulating factor in determining orthotic compliance outcomes. For an aging caregiver, with a young adult dependent in self-care, a daily wearing schedule may be an unrealistic goal. An alternative orthosis or wear schedule may be needed to assist with caregiver compliance. (Source: JPO Journal of Prosthetics and Orthotics)